126 related articles for article (PubMed ID: 20806340)
1. Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides.
M'Koma AE; Seeley EH; Washington MK; Schwartz DA; Muldoon RL; Herline AJ; Wise PE; Caprioli RM
Inflamm Bowel Dis; 2011 Apr; 17(4):875-83. PubMed ID: 20806340
[TBL] [Abstract][Full Text] [Related]
2. Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease.
Myers JN; Schäffer MW; Korolkova OY; Williams AD; Gangula PR; M'Koma AE
Inflamm Bowel Dis; 2014 Sep; 20(9):1530-47. PubMed ID: 25078150
[TBL] [Abstract][Full Text] [Related]
3. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.
Rana T; Korolkova OY; Rachakonda G; Williams AD; Hawkins AT; James SD; Sakwe AM; Hui N; Wang L; Yu C; Goodwin JS; Izban MG; Offodile RS; Washington MK; Ballard BR; Smoot DT; Shi XZ; Forbes DS; Shanker A; M'Koma AE
PLoS One; 2021; 16(3):e0246393. PubMed ID: 33690604
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal DNA methylation profiling of the rectal mucosa identifies cell-specific signatures of disease status, severity and clinical outcomes in ulcerative colitis cell-specific DNA methylation signatures of UC.
Venkateswaran S; Somineni HK; Matthews JD; Kilaru V; Hyams JS; Denson LA; Kellamayer R; Gibson G; Cutler DJ; Conneely KN; Smith AK; Kugathasan S
Clin Epigenetics; 2023 Mar; 15(1):50. PubMed ID: 36964596
[TBL] [Abstract][Full Text] [Related]
5. Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.
de Frias Gomes CG; de Almeida ASR; Mendes CCL; Ellul P; Burisch J; Buhagiar T; Attard A; Lo B; Ungaro RC; da Silva Morão BT; Gouveia CF; de Carvalho E Branco JMD; Rodrigues JMMP; Teixeira C; Dias de Castro MFF; Nunes GFD; Brito M; de Sousa Antunes MC; Borralho Nunes PMFB; da Silva Torres JMT
Inflamm Bowel Dis; 2022 Mar; 28(3):350-357. PubMed ID: 33999195
[TBL] [Abstract][Full Text] [Related]
6. T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease.
Williams KG; Kongala R; Shows DM; Konecny AJ; Hindmarch DC; Clarke AS; Lord JD
Cell Mol Gastroenterol Hepatol; 2024; 17(1):119-130. PubMed ID: 37714427
[TBL] [Abstract][Full Text] [Related]
7. Role of through-the-scope catheter-based EUS in inflammatory bowel disease diagnosis and activity assessment.
Nguyen VQ; Celio F; Chitnavis M; Shakhatreh M; Katz J; Cominelli F; Chak A; Yeaton P
Gastrointest Endosc; 2023 Apr; 97(4):752-758.e2. PubMed ID: 36343674
[TBL] [Abstract][Full Text] [Related]
8. Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort.
Vatn SS; Lindstrøm JC; Moen AEF; Brackmann S; Tannæs TM; Olbjørn C; Bergemalm D; Keita ÅV; Gomollon F; Detlie TE; Lüders T; Kalla R; Adams A; Satsangi J; Jahnsen J; Vatn MH; Halfvarson J; Ricanek P; Nilsen H;
Clin Exp Gastroenterol; 2022; 15():5-25. PubMed ID: 35185343
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization of Limited Ulcerative Colitis Reveals Novel Biology and Predictors of Disease Extension.
Argmann C; Tokuyama M; Ungaro RC; Huang R; Hou R; Gurunathan S; Kosoy R; Di'Narzo A; Wang W; Losic B; Irizar H; Peters L; Stojmirovic A; Wei G; Comella PH; Curran M; Brodmerkel C; Friedman JR; Hao K; Schadt EE; Zhu J; Cho J; Harpaz N; Dubinsky MC; Sands BE; Kasarskis A; Mehandru S; Colombel JF; Suárez-Fariñas M
Gastroenterology; 2021 Dec; 161(6):1953-1968.e15. PubMed ID: 34480882
[TBL] [Abstract][Full Text] [Related]
10. Patients With Microscopic Colitis Have Altered Levels of Inhibitory and Stimulatory Biomarkers in Colon Biopsies and Sera Compared to Non-inflamed Controls.
Lushnikova A; Bohr J; Wickbom A; Münch A; Sjöberg K; Hultgren O; Wirén A; Hultgren Hörnquist E
Front Med (Lausanne); 2021; 8():727412. PubMed ID: 34722568
[No Abstract] [Full Text] [Related]
11. Multi-Omics Characterization of Colon Mucosa and Submucosa/Wall from Crohn's Disease Patients.
Jin L; Macoritto M; Wang J; Bi Y; Wang F; Suarez-Fueyo A; Paez-Cortez J; Hu C; Knight H; Mascanfroni I; Staron MM; Schwartz Sterman A; Houghton JM; Westmoreland S; Tian Y
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791146
[TBL] [Abstract][Full Text] [Related]
12. Metabolic analyses reveal dysregulated NAD+ metabolism and altered mitochondrial state in ulcerative colitis.
Kang YH; Tucker SA; Quevedo SF; Inal A; Korzenik JR; Haigis MC
PLoS One; 2022; 17(8):e0273080. PubMed ID: 35976971
[TBL] [Abstract][Full Text] [Related]
13. Serum protein profiling of adults and children with Crohn disease.
Vaiopoulou A; Gazouli M; Papadopoulou A; Anagnostopoulos AK; Karamanolis G; Theodoropoulos GE; M'Koma A; Tsangaris GT
J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):42-7. PubMed ID: 25250685
[TBL] [Abstract][Full Text] [Related]
14. A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review.
Fabian O; Bajer L; Drastich P; Harant K; Sticova E; Daskova N; Modos I; Tichanek F; Cahova M
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298338
[TBL] [Abstract][Full Text] [Related]
15. Molecular Activity of Inflammation and Epithelial-Mesenchymal Transition in the Microenvironment of Ulcerative Colitis.
Jun YK; Kim N; Yoon H; Park JH; Kim HK; Choi Y; Lee JA; Shin CM; Park YS; Lee DH
Gut Liver; 2024 Feb; ():. PubMed ID: 38384179
[TBL] [Abstract][Full Text] [Related]
16. Proteomic and lipidomic biomarkers in the diagnosis and progression of inflammatory bowel disease - a review.
Cecerska-Heryć E; Ronkowski B; Heryć R; Serwin N; Grygorcewicz B; Roszak M; Galant K; Dołęgowska B
Proteomics Clin Appl; 2023 Jan; 17(1):e2200003. PubMed ID: 36043901
[TBL] [Abstract][Full Text] [Related]
17. A Tale of Two Colitides.
Provenzano N; Forker L; Berman L; Belser P; Govil Y
Cureus; 2022 Mar; 14(3):e23677. PubMed ID: 35505712
[TBL] [Abstract][Full Text] [Related]
18.
Levic DS; Niedzwiecki D; Kandakatla A; Karlovich NS; Juneja A; Park J; Stolarchuk C; Adams S; Willer JR; Schaner MR; Lian G; Beasley C; Marjoram L; Flynn AD; Valentine JF; Onken JE; Sheikh SZ; Davis EE; Evason KJ; Garman KS; Bagnat M
medRxiv; 2024 Feb; ():. PubMed ID: 38370739
[TBL] [Abstract][Full Text] [Related]
19. Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa.
Zeren S; Seker S; Akgün GA; Okur E; Yerlikaya A
Med Oncol; 2023 Sep; 40(10):298. PubMed ID: 37707637
[TBL] [Abstract][Full Text] [Related]
20.
Ding H; Dupont AW; Singhal S; Scott LD; Guha S; Younes M; Bi X
Biomed Opt Express; 2017 Jul; 8(7):3426-3439. PubMed ID: 28717578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
